|
■Principal Area of Business |
Venture company with core technology consisting of the expression of recombinant proteins in the cocoons of transgenic silkworms. Produces recombinant proteins in a large scale and develops silk-based new materials for pharmaceutical and medical purposes. |
|
■Principal Products/Business Activities |
l Recombinant protein production services-recombinant protein production services using transgenic silkworms (small and large-scale)
l Development of silk fiber carrying novel functions- Neosilk develops a new functionalized silk fiber by expressing recombinant proteins fused with fibroin. This new silk may offer a unique bio material for medical use since the materials have silk’s high tissue compatibility coupled with the characteristics of recombinant proteins. |